These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 6149947)

  • 1. Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.
    Nakaya H; Kimura S; Nakao Y; Kanno M
    Eur J Pharmacol; 1984 Sep; 104(3-4):335-44. PubMed ID: 6149947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of propranolol on premature action potentials in canine Purkinje and ventricular muscle.
    Varró A; Lathrop DA; Surawicz B
    J Cardiovasc Pharmacol; 1990 Nov; 16(5):757-63. PubMed ID: 1703597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium.
    Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
    Jpn J Pharmacol; 1995 Jun; 68(2):175-82. PubMed ID: 7563974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic basis of the antiarrhythmic and hemodynamic effects of sotalol.
    Antonaccio MJ; Gomoll A
    Am J Cardiol; 1993 Aug; 72(4):27A-37A. PubMed ID: 8346723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of isocorydine on action potentials in isolated canine Purkinje fibers and ventricular muscles.
    Zhao YQ; Li GR; Zhang DZ; Zhao GS
    Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):324-7. PubMed ID: 1807081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The electrophysiologic effects of ersentilide on canine hearts.
    Lee JH; Rosenshtraukh L; Beloshapko G; Rosen MR
    Eur J Pharmacol; 1995 Oct; 285(1):25-35. PubMed ID: 8846808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK; Gelband H; Bassett AL
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiological effects of nipradilol (K-351) on isolated rabbit hearts and guinea pig ventricular muscles.
    Kodama I; Anno T; Toyama J; Yamada K
    J Cardiovasc Pharmacol; 1985; 7(6):1013-9. PubMed ID: 2418282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the electrophysiologic response of four canine ventricular cell types to alpha 1-adrenergic agonists.
    Burashnikov A; Antzelevitch C
    Cardiovasc Res; 1999 Sep; 43(4):901-8. PubMed ID: 10615417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiologic activity and antiarrhythmic efficacy of CK-3579, a new class III antiarrhythmic agent with beta-adrenergic blocking properties.
    Argentieri TM; Troy HH; Carroll MS; Doroshuk CM; Sullivan ME
    J Cardiovasc Pharmacol; 1993 Apr; 21(4):647-55. PubMed ID: 7681912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the electrophysiological effects of ambasilide, a new antiarrhythmic agent, in canine isolated ventricular muscle and purkinje fibers.
    Baláti B; Iost N; Simon J; Varró A; Papp JG
    Gen Pharmacol; 2000 Feb; 34(2):85-93. PubMed ID: 10974415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic properties of UK-66,914, a novel class III antiarrhythmic agent.
    Gwilt M; Dalrymple HW; Burges RA; Blackburn KJ; Dickinson RP; Cross PE; Higgins AJ
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):376-85. PubMed ID: 1711597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular electrophysiology and beta-adrenergic-blocking activity of dilevalol, the R,R-isomer of labetalol, on isolated canine cardiac tissues.
    Zaim S; Dangman KH
    J Cardiovasc Pharmacol; 1989 Sep; 14(3):496-501. PubMed ID: 2476632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental cellular electrophysiologic effects of d-sotalol on canine cardiac Purkinje fibers.
    Moak JP
    Pediatr Res; 1991 Jan; 29(1):104-9. PubMed ID: 2000254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative beta-blocking activities and electrophysiologic actions of racemic sotalol and its optical isomers in anesthetized dogs.
    Gomoll AW; Bartek MJ
    Eur J Pharmacol; 1986 Dec; 132(2-3):123-35. PubMed ID: 2880732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiologic effects of the levo- and dextrorotatory isomers of sotalol in isolated cardiac muscle and their in vivo pharmacokinetics.
    Kato R; Ikeda N; Yabek SM; Kannan R; Singh BN
    J Am Coll Cardiol; 1986 Jan; 7(1):116-25. PubMed ID: 3941198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifibrillatory properties of the beta-adrenergic receptor antagonists, nadolol, sotalol, atenolol and propranolol, in the anesthetized dog.
    Patterson E; Lucchesi BR
    Pharmacology; 1984; 28(3):121-9. PubMed ID: 6144114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic effects of ambasilide (LU 47110), a novel class III antiarrhythmic agent, on the properties of isolated rabbit and canine cardiac muscle.
    Takanaka C; Sarma JS; Singh BN
    J Cardiovasc Pharmacol; 1992 Feb; 19(2):290-8. PubMed ID: 1376799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.